Ground Swell Capital’s Northwest Biotherapeutics, Inc. NWBOW Stock Holding History

Ground Swell Capital’s Portfolio NWBOW Stock Details NWBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-199	Closed	-$1K	–	3233
2014 Q2	$1K	Buy	+199	New	+$788	﹤0.01%	1952

Other funds holding NWBOW

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Ground Swell Capital's NWBOW Position: Q3 2014 in Review

Ground Swell Capital sold out of Northwest Biotherapeutics, Inc. (NWBOW) in Q3 2014, closing a stake of 199 shares — an estimated $1K sold.

Ground Swell Capital first reported a position in NWBOW in Q2 2014 and held it in 1 quarter. The position peaked at $1K in Q2 2014. 2 funds tracked by Wall St. Rank hold NWBOW as of Q3 2014.

Ground Swell Capital reported no remaining Northwest Biotherapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
Ground Swell Capital sold 199 Northwest Biotherapeutics, Inc. shares in Q3 2014, an estimated $1K.
Ground Swell Capital first reported a position in Northwest Biotherapeutics, Inc. in Q2 2014 and held it in 1 quarter.
Ground Swell Capital's Northwest Biotherapeutics, Inc. position peaked at $1K in Q2 2014.
2 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.